Class IITerminatedD-104-2013
Drug recall · January 2, 2013
Levothyroxine Sodium Tablets recall
Why: Subpotent; 15 month stability
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levothyroxine Sodium Tablets, USP, 175 mcg in 90 ct bottles, Manufactured by Patheon Puerto Rico Inc., for Alara Pharmaceutical Corp, San Juan, PR
- Lots / codes
11T7011A, Exp. Date: 12/2012
- Quantity
- 7,432 bottles
- Company
- Alara Pharmaceutical Co, San Juan, PR
- Distribution
- Nationwide
- Initiated
- October 29, 2012 · Voluntary: Firm initiated
- Classified
- December 21, 2012
- Reported
- January 2, 2013
- Ended
- January 3, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levothyroxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.